Halozyme Therapeutics reported $204.94M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 40.21M 12.43M Jun/2025
Agios Pharmaceuticals USD -112020000 22.73M Jun/2025
Alnylam Pharmaceuticals USD -35358000 6.24M Jun/2025
Amarin USD -13630000 197K Mar/2025
Amgen USD 1.57B 405M Jun/2025
Baxter International USD -3000000 286M Mar/2025
Cytokinetics USD -134370000 27.01M Jun/2025
DBV Technologies EUR -41758000 18.75M Jun/2025
Eli Lilly USD 6.78B 3.32B Jun/2025
Halozyme Therapeutics USD 204.94M 61.11M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
MannKind USD 940K 12.68M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
United Therapeutics USD 408.4M 15.1M Jun/2025